Cd134 Antibody / Ox40
Tumor necrosis factor receptor superfamily, member 4, also known as ACT35 or CD134, is a cell surface glycoprotein that was discovered through the production of a monoclonal antibody raised against the HUT-102 cell line. It belongs to the tumor necrosis factor receptor superfamily. CD134 was mapped to 1p36 by fluorescence in situ hybridization. It is the primary receptor for feline immunodeficiency virus. And CD134 expression can promote viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Stimulating the receptor can improve the response to a powerful virus vector and may be useful in vaccine development.
Product Specifications
CAS Number
9007-83-4
Specifications
Western blot: 0.5-1 µg/mL, Direct ELISA: 0.1-0.5 µg/mL (rat recombinant protein)
UniProt
P15725
Host
Rabbit
Reactivity
Rat
Immunogen
A recombinant rat protein corresponding to amino acids V20-L198 was used as the immunogen for the Cd134 antibody.
Clonality
Polyclonal
Isotype
IgG
Applications
WB, ELISA
Purity
Antigen affinity purified
Format
Antigen affinity purified
Buffer
Lyophilized from 1X PBS with 2% Trehalose and 0.025% sodium azide
Reconstitution
Limitations
This Cd134 antibody is available for research use only.
Storage Conditions
Formulation
0.5 mg/mL if reconstituted with 0.2ml sterile DI water
Applications Notes
Optimal dilution of the Cd134 antibody should be determined by the researcher.
Location
Cytoplasm, membrane
Image Legend
Western blot testing of rat heart lysate with Cd134 antibody at 0.5ug/ml. Expected molecular weight: 29-50 kDa depending on glcyosylation level.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog